Heartbeam Inc reports results for the quarter ended December 31 - Earnings Summary

Heartbeam

13/03/2025 21:01

Heartbeam Inc BEAT.OQ reported a quarterly adjusted loss of 18 cents​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -15 cents.  The lone analyst forecast for the quarter was for a loss of 19 cents per share.

Reported revenue was zero​; analysts expected zero.

Heartbeam Inc's reported EPS for the quarter was a loss of 18 cents​.

The company reported a quarterly loss of $4.91 million.

Heartbeam Inc shares had fallen by 9.6% this quarter.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 2.6% in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The average consensus recommendation for the advanced medical equipment & technology peer group is  "hold."

Wall Street's median 12-month price target for Heartbeam Inc is $5.00

This summary was machine generated from LSEG data March 13 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Dec. 31 2024
-0.19
-0.18
Beat
Sep. 30 2024
-0.17
-0.19
Missed
Jun. 30 2024
-0.16
-0.19
Missed
Mar. 31 2024
-0.15
-0.17
Missed